Browse by Poster Title

Type here to filter the list

Sort by #

Sort by Title

D
P 177
DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING

Favorite
P 176
DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS

Favorite
P 23
DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA

Favorite
P 110
DEFINITIVE RADIATION THERAPY IN "OPERABLE" EWING SARCOMA OF THE EXTREMITIES AND PELVIS

Favorite
P 114
DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES

Favorite
P 263
DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING

Favorite
P 356
DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER

Favorite
P 229
DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY

Favorite
P 26
DEVELOPING AN ORTHOTOPIC MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR

Favorite
P 173
DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA

Favorite
P 357
DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET

Favorite
P 119
DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES

Favorite
P 237
DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA

Favorite
P 455
DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT

Favorite
P 197
DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO

Favorite
P 392
DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES

Favorite
P 82
DISPARITIES IN OSTEOSARCOMA BY SOCIOECONOMIC STATUS

Favorite
P 200
DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS

Favorite
P 37
DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS

Favorite
P 108
DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION

Favorite
P 374
DISTINCT PATTERNS OF METASTATIC SPREAD IN LEIOMYOSARCOMA: A COMPARATIVE ANALYSIS OF TRUNCAL AND EXTREMITY TUMOURS

Favorite
P 393
DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS

Favorite
P 12
DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY

Favorite
P 233
DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)

Favorite
P 222
DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS

Favorite
P 111
DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS

Favorite
P 375
DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS

Favorite
P 153
DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.

Favorite
P 234
DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS

Favorite
P 394
DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST

Favorite
P 322
DYNAMIC PET/MRI REVEALS METABOLIC-DIFFUSION INTERACTIONS IN SUSPECTED SOFT TISSUE SARCOMAS

Favorite